Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Dermatology
•
General Dermatology
•
Pediatric Dermatology
How has the recently FDA-approved topical cantharidin altered your molluscum treatment algorithm?
Are you considering also using it for the treatment of warts?
Related Questions
What role do you feel that dermatologists play in the management of patients with Ehlers Danlos syndrome?
What’s your approach to recurrent “idiopathic” Erythema Nodosum that failed NSAIDs?
What therapies do you most commonly recommend for patients with bromohidrosis?
Is narrow-band ultraviolet B (nbUVB) phototherapy contraindicated or recommended with caution in patients with a personal history of melanoma?
What approach(es) do you take to treat pyoderma gangrenosum with superimposed infection?
How do you counsel parents of children with atopic dermatitis about preventing recurrent Staph infections?
What oral therapies have you found helpful for managing seborrheic dermatitis?
What therapies have you found most effective in treating post-inflammatory hyperpigmentation due to rashes such as a fixed drug eruption?
How do you counsel patients who report a history of a lidocaine allergy?
How do you manage atopic dermatitis in pediatric patients who has failed dupilumab?